Gen-Probe Reports Financial Results for Second Qu...(ation of premiums on investments ...),Health

Date:7/30/2009

ation of premiums on investments, net of accretion of discounts 2,720 3,504 Stock-based compensation 11,405 9,228 Stock-based compensation income tax benefits 310 1,294 Excess tax benefit from stock-based compensation (702) (614) Deferred revenue (255) (3,165) Deferred income tax (1,041) (821) Gain on sale of investment in MPI - (1,600) Impairment of intangible assets - 3,496 Loss / (gain) on disposal of property and equipment 69 (1) Changes in assets and liabilities: Trade and other accounts receivable 1,372 3,290 Inventories 3,890 (2,749) Prepaid expenses 3,137 5,333 Other current assets 2,081 (1,322) Goodwill 856 - Other long-term assets (2,486) (909) Accounts payable (2,218) 3,992 Accrued salaries and employee benefits (7,272) (1,732) Other accrued expenses 1,337 (9) Income tax payable (3,704) (72) Other long-term liabilities 335 603 --- --- Net cash provided by operating activities 74,859 91,715 ------
'/>"/>

SOURCE Gen-Probe Incorporated Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Reports Financial Results for First Quarter 2009
3. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
4. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
5. Tepnel Shareholders Approve Acquisition by Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
7. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
8. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
9. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
10. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference